Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Price:
20.48
CNY
-0.24%
Market Closed
Market Cap:
¥3.7B
Balance Sheet
Balance Sheet Decomposition
Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Bio-Tech Co Ltd
Balance Sheet Decomposition is not available for
Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Bio-Tech Co Ltd
Balance Sheet
Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Bio-Tech Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
20
|
130
|
104
|
99
|
132
|
78
|
193
|
113
|
57
|
59
|
112
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
113
|
57
|
59
|
112
|
|
| Cash Equivalents |
20
|
130
|
104
|
99
|
132
|
78
|
193
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
376
|
252
|
445
|
534
|
599
|
505
|
|
| Total Receivables |
24
|
28
|
36
|
45
|
45
|
52
|
56
|
52
|
50
|
55
|
52
|
|
| Accounts Receivables |
23
|
28
|
35
|
44
|
44
|
51
|
55
|
47
|
46
|
51
|
48
|
|
| Other Receivables |
0
|
0
|
2
|
2
|
1
|
2
|
1
|
5
|
4
|
4
|
3
|
|
| Inventory |
6
|
7
|
6
|
9
|
12
|
18
|
24
|
34
|
41
|
37
|
35
|
|
| Other Current Assets |
1
|
1
|
42
|
304
|
316
|
2
|
3
|
20
|
28
|
21
|
9
|
|
| Total Current Assets |
50
|
166
|
188
|
457
|
505
|
526
|
527
|
663
|
710
|
771
|
713
|
|
| PP&E Net |
25
|
24
|
24
|
25
|
33
|
150
|
234
|
220
|
228
|
243
|
230
|
|
| PP&E Gross |
25
|
24
|
24
|
25
|
33
|
150
|
234
|
220
|
228
|
243
|
230
|
|
| Accumulated Depreciation |
20
|
23
|
26
|
28
|
30
|
33
|
36
|
50
|
66
|
83
|
102
|
|
| Intangible Assets |
6
|
9
|
19
|
18
|
43
|
42
|
41
|
38
|
37
|
35
|
33
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
2
|
2
|
29
|
31
|
3
|
3
|
4
|
7
|
12
|
5
|
5
|
|
| Total Assets |
82
N/A
|
200
+143%
|
259
+29%
|
531
+105%
|
584
+10%
|
720
+23%
|
806
+12%
|
929
+15%
|
987
+6%
|
1 054
+7%
|
980
-7%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
8
|
7
|
13
|
52
|
66
|
57
|
34
|
21
|
17
|
|
| Accrued Liabilities |
6
|
7
|
5
|
11
|
10
|
16
|
12
|
24
|
22
|
16
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
22
|
26
|
13
|
25
|
18
|
5
|
|
| Other Current Liabilities |
2
|
7
|
8
|
13
|
18
|
24
|
41
|
32
|
25
|
35
|
47
|
|
| Total Current Liabilities |
8
|
13
|
20
|
31
|
41
|
114
|
145
|
126
|
106
|
90
|
81
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
6
|
7
|
6
|
|
| Other Liabilities |
10
|
8
|
11
|
17
|
14
|
18
|
14
|
10
|
10
|
9
|
5
|
|
| Total Liabilities |
19
N/A
|
21
+12%
|
31
+48%
|
48
+54%
|
55
+16%
|
132
+140%
|
159
+20%
|
144
-10%
|
122
-15%
|
106
-13%
|
91
-14%
|
|
| Equity | ||||||||||||
| Common Stock |
24
|
60
|
60
|
80
|
80
|
80
|
120
|
120
|
180
|
180
|
180
|
|
| Retained Earnings |
22
|
27
|
72
|
134
|
180
|
239
|
297
|
436
|
516
|
599
|
589
|
|
| Additional Paid In Capital |
15
|
91
|
94
|
269
|
269
|
269
|
229
|
229
|
169
|
169
|
169
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
|
| Other Equity |
3
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
64
N/A
|
179
+182%
|
228
+27%
|
483
+112%
|
529
+9%
|
588
+11%
|
647
+10%
|
785
+21%
|
865
+10%
|
948
+10%
|
889
-6%
|
|
| Total Liabilities & Equity |
82
N/A
|
200
+143%
|
259
+29%
|
531
+105%
|
584
+10%
|
720
+23%
|
806
+12%
|
929
+15%
|
987
+6%
|
1 054
+7%
|
980
-7%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
90
|
90
|
90
|
120
|
120
|
120
|
120
|
180
|
180
|
180
|
178
|
|
Switch to:
Switch to:
See Also
Discover More
